SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (12915)1/1/1998 4:24:00 PM
From: Andrew H  Read Replies (1) of 32384
 
>>There is also evidence showing decreading PSA levels when prostate cancer patients are treated, and of course new cases of prostate cancer is 10 times higher than KS (using LGND's fall of '96 cheat sheet).<<

Henry, what is this "cheat sheet?" Is it available online?

As far as profitability in 4Q 98, its hard to imagine. If everything goes very smoothly, Panretin may be on the market by that time, but would be unlikely to have enough sales to make a profit, unless they are expecting a large milestone payment or some such thing at that time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News